Isbn: 9786189451192 - life expectancy in cancer survivors (9 resultados)

ISBN: 
Refinar con la Búsqueda avanzada

Filtrar la búsqueda

  • Libros (9)

  • Nuevo (9)

a

Intervalo de precios personalizado (EUR)

a

  • Idioma: Inglés

    Editorial: Rashid Publications, 2026

    6189451195 / 9786189451192

    • Tapa blanda

    Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 12,73

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    Condición: New.

  • Idioma: Inglés

    Editorial: RASHID PUBLICATIONS, 2026

    6189451195 / 9786189451192

    • Tapa blanda

    Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de AmericaPBShop.store US

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 13,72

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

  • Idioma: Inglés

    Editorial: RASHID PUBLICATIONS, 2026

    6189451195 / 9786189451192

    • Tapa blanda

    Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 13,34

    Envío por EUR 3,85 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

  • Idioma: Inglés

    Editorial: Rashid Publications, 2026

    6189451195 / 9786189451192

    • Tapa blanda

    Librería: KALAMO BOOKS, Burriana, CS, EspañaKALAMO BOOKS

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 8,45

    Envío por EUR 19,86 
    Se envía de España a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Condición: New.

  • Idioma: Inglés

    Editorial: Rashid Publications, 2026

    6189451195 / 9786189451192

    • Tapa blanda
    • Impresión bajo demanda

    Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 12,72

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 1 disponible

    Paperback. Condición: new. Paperback. Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied. These customized estimates can complement existing risk prediction tools and inform personalized decisions about the benefits and timing of LC screening in this potentially high-risk group. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Idioma: Inglés

    Editorial: RASHID PUBLICATIONS, 2026

    6189451195 / 9786189451192

    • Tapa blanda
    • Impresión bajo demanda

    Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 14,53

    Envío por EUR 35,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied.…

  • Idioma: Inglés

    Editorial: Rashid Publications, 2026

    6189451195 / 9786189451192

    • Tapa blanda
    • Impresión bajo demanda

    Librería: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 21,38

    Envío por EUR 32,67 
    Se envía de Australia a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Paperback. Condición: new. Paperback. Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied. These customized estimates can complement existing risk prediction tools and inform personalized decisions about the benefits and timing of LC screening in this potentially high-risk group. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

  • Idioma: Inglés

    Editorial: Rashid Publications, 2026

    6189451195 / 9786189451192

    • Tapa blanda
    • Impresión bajo demanda

    Librería: CitiRetail, Stevenage, Reino UnidoCitiRetail

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 16,87

    Envío por EUR 43,33 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Paperback. Condición: new. Paperback. Breast cancer (BC) survivors may face a higher risk of developing second primary cancers compared to individuals without a BC diagnosis due to shared risk factors and potential carcinogenic effects of cancer therapy. Lung cancer (LC) is the most common second primary cancer among BC survivors. However, the degree to which a prior BC diagnosis increases the risk of subsequent LC remains uncertain, as previous studies have reported mixed findings. Our first analysis utilized clinical data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. We found BC diagnosis was an independent risk factor for developing a second primary LC after adjustment for established risk factors. Similarly, the improved longevity of prostate cancer (PC) survivors has heightened the clinical importance of understanding and addressing secondary health risks, such as the development of LC. Nonetheless, the risk of LC in PC survivors has been underestimated and remains under-studied. These customized estimates can complement existing risk prediction tools and inform personalized decisions about the benefits and timing of LC screening in this potentially high-risk group. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

  • Idioma: Inglés

    Editorial: RASHID PUBLICATIONS, 2026

    6189451195 / 9786189451192

    • Tapa blanda
    • Impresión bajo demanda

    Librería: preigu, Osnabrück, Alemaniapreigu

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 14,00

    Envío por EUR 70,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 5 disponibles

    Taschenbuch. Condición: Neu. Life Expectancy In Cancer Survivors | Mohd Rashid | Taschenbuch | Englisch | 2026 | RASHID PUBLICATIONS | EAN 9786189451192 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.